Ratings Hexima Limited

Equities

Market Closed - Australian Stock Exchange Other stock markets 10:43:53 2023-12-05 pm EST			5-day change	1st Jan Change
0.018 ^AUD	0.00%		-21.74%	-10.00%

Nov. 29	Hexima Limited Announces the Resignation of Dr. Nicole Van Der Weerden as Director	CI
Sep. 19	Hexima Limited Appoints Phillip Hains as A Non-Executive Director	CI

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
HEXIMA LIMITED	-10.00%	2 M $	-	-
SEAGEN INC.	+69.74%	40 713 M $		B
IQVIA HOLDINGS INC.	+4.18%	39 345 M $		B
MODERNA, INC.	-55.78%	30 731 M $		B-
LONZA GROUP AG	-27.50%	28 435 M $		A
ICON PUBLIC LIMITED COMPANY	+37.57%	22 100 M $		B-
ALNYLAM PHARMACEUTICALS, INC.	-25.48%	21 964 M $		B
CELLTRION, INC.	-1.81%	16 910 M $		C
UNITED THERAPEUTICS CORPORATION	-13.62%	11 278 M $		B+
BIO-TECHNE CORPORATION	-18.81%	10 444 M $		B+

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality